Cargando…

Identification of genetic instability in peripheral blood lymphocyte of oral squamous cell carcinoma patients assess by comet assay

CONTEXT: Studies established that human cancer is principally a genetic disease; it arises as accumulation of a set of genetic changes. In the pathogenesis of cancer, genetic instability is the sequential event to a carcinogenic stimulus resulting in various genomic changes including DNA damage. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekate, Kamlesh, Barpande, Suresh, Tupkari, Jagdish, Thakur, Mansee, Swain, Niharika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364639/
https://www.ncbi.nlm.nih.gov/pubmed/35968167
http://dx.doi.org/10.4103/jomfp.jomfp_70_20
_version_ 1784765186065825792
author Dekate, Kamlesh
Barpande, Suresh
Tupkari, Jagdish
Thakur, Mansee
Swain, Niharika
author_facet Dekate, Kamlesh
Barpande, Suresh
Tupkari, Jagdish
Thakur, Mansee
Swain, Niharika
author_sort Dekate, Kamlesh
collection PubMed
description CONTEXT: Studies established that human cancer is principally a genetic disease; it arises as accumulation of a set of genetic changes. In the pathogenesis of cancer, genetic instability is the sequential event to a carcinogenic stimulus resulting in various genomic changes including DNA damage. AIMS: To assess genetic instability, as susceptibility to DNA damage, we used single-cell gel electrophoresis (comet assay) to study double strand breaks in associated with the risk of oral squamous cell carcinoma (OSCC). MATERIALS AND METHODS: We used comet assay to measure double strand break in individual peripheral blood lymphocytes from 50 individuals with OSCC and 30 healthy control subjects. All personal information was gathered from subjects including tobacco history. DNA damage was visualized as comet assay and quantified by movement of damaged strands as length of tail. RESULTS: Study results of OSCC patients were observed in relation to clinical staging and histological grading of carcinoma. On the basis of clinical observation, cases were grouped in to Stage I, Stage II, Stage III and Stage IV. No stage I cases were in study sample. The mean DNA damage migration length was observed 4.600 ± 0.4613 μm in stage II, whereas in Stage III and Stage IV, it was observed to be 4.961 ± 0.5620 μm and 4.883 ± 0.410 μm, respectively. The DNA damage length in histological grades of squamous cell carcinoma patients in Grade I was 4.6437 ± 0.3061 μm and Grade II was 5.3533 ± 0.3831 μm. In comparison with control group and squamous cell carcinoma group, it was observed in the range of 0.02–0.36 μm and varied from 4.04 to 5.84 μm range, respectively. Thus, the results were statistically significant with the histological grading of OSCC. STATISTICAL ANALYSIS: Unpaired' test and “ANOVA” test are used for statistics. STATISTICAL ANALYSIS: Unpaired' test and “ANOVA” test are used for statistics. CONCLUSION: The amount of DNA strand breaks in peripheral lymphocytes are measured by comet assay which is associated with relative risk of OSCC.
format Online
Article
Text
id pubmed-9364639
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93646392022-08-11 Identification of genetic instability in peripheral blood lymphocyte of oral squamous cell carcinoma patients assess by comet assay Dekate, Kamlesh Barpande, Suresh Tupkari, Jagdish Thakur, Mansee Swain, Niharika J Oral Maxillofac Pathol Original Article CONTEXT: Studies established that human cancer is principally a genetic disease; it arises as accumulation of a set of genetic changes. In the pathogenesis of cancer, genetic instability is the sequential event to a carcinogenic stimulus resulting in various genomic changes including DNA damage. AIMS: To assess genetic instability, as susceptibility to DNA damage, we used single-cell gel electrophoresis (comet assay) to study double strand breaks in associated with the risk of oral squamous cell carcinoma (OSCC). MATERIALS AND METHODS: We used comet assay to measure double strand break in individual peripheral blood lymphocytes from 50 individuals with OSCC and 30 healthy control subjects. All personal information was gathered from subjects including tobacco history. DNA damage was visualized as comet assay and quantified by movement of damaged strands as length of tail. RESULTS: Study results of OSCC patients were observed in relation to clinical staging and histological grading of carcinoma. On the basis of clinical observation, cases were grouped in to Stage I, Stage II, Stage III and Stage IV. No stage I cases were in study sample. The mean DNA damage migration length was observed 4.600 ± 0.4613 μm in stage II, whereas in Stage III and Stage IV, it was observed to be 4.961 ± 0.5620 μm and 4.883 ± 0.410 μm, respectively. The DNA damage length in histological grades of squamous cell carcinoma patients in Grade I was 4.6437 ± 0.3061 μm and Grade II was 5.3533 ± 0.3831 μm. In comparison with control group and squamous cell carcinoma group, it was observed in the range of 0.02–0.36 μm and varied from 4.04 to 5.84 μm range, respectively. Thus, the results were statistically significant with the histological grading of OSCC. STATISTICAL ANALYSIS: Unpaired' test and “ANOVA” test are used for statistics. STATISTICAL ANALYSIS: Unpaired' test and “ANOVA” test are used for statistics. CONCLUSION: The amount of DNA strand breaks in peripheral lymphocytes are measured by comet assay which is associated with relative risk of OSCC. Wolters Kluwer - Medknow 2022 2022-06-28 /pmc/articles/PMC9364639/ /pubmed/35968167 http://dx.doi.org/10.4103/jomfp.jomfp_70_20 Text en Copyright: © 2022 Journal of Oral and Maxillofacial Pathology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Dekate, Kamlesh
Barpande, Suresh
Tupkari, Jagdish
Thakur, Mansee
Swain, Niharika
Identification of genetic instability in peripheral blood lymphocyte of oral squamous cell carcinoma patients assess by comet assay
title Identification of genetic instability in peripheral blood lymphocyte of oral squamous cell carcinoma patients assess by comet assay
title_full Identification of genetic instability in peripheral blood lymphocyte of oral squamous cell carcinoma patients assess by comet assay
title_fullStr Identification of genetic instability in peripheral blood lymphocyte of oral squamous cell carcinoma patients assess by comet assay
title_full_unstemmed Identification of genetic instability in peripheral blood lymphocyte of oral squamous cell carcinoma patients assess by comet assay
title_short Identification of genetic instability in peripheral blood lymphocyte of oral squamous cell carcinoma patients assess by comet assay
title_sort identification of genetic instability in peripheral blood lymphocyte of oral squamous cell carcinoma patients assess by comet assay
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364639/
https://www.ncbi.nlm.nih.gov/pubmed/35968167
http://dx.doi.org/10.4103/jomfp.jomfp_70_20
work_keys_str_mv AT dekatekamlesh identificationofgeneticinstabilityinperipheralbloodlymphocyteoforalsquamouscellcarcinomapatientsassessbycometassay
AT barpandesuresh identificationofgeneticinstabilityinperipheralbloodlymphocyteoforalsquamouscellcarcinomapatientsassessbycometassay
AT tupkarijagdish identificationofgeneticinstabilityinperipheralbloodlymphocyteoforalsquamouscellcarcinomapatientsassessbycometassay
AT thakurmansee identificationofgeneticinstabilityinperipheralbloodlymphocyteoforalsquamouscellcarcinomapatientsassessbycometassay
AT swainniharika identificationofgeneticinstabilityinperipheralbloodlymphocyteoforalsquamouscellcarcinomapatientsassessbycometassay